ChemBriefUS FDA Advisory Panel Endorses Grail Cancer Test Benefits
US FDA advisers voted 7-2 that Grail's Galleri blood-based cancer test benefits outweigh risks, paving the way for potential nationwide approval. The test detects multiple cancers from a single blood
reuters · 2026-09-23 15:05 UTC